Indian Pacing Electrophysiol. J.

ISSN 0972-6292


Home Page Current Issue List of Editors

Indian Pacing Electrophysiol. J. 2009;9(3):167-173                     Original Article

Isthmus Dependent Atrial Flutter Cycle Length Correlates with Right Atrial Cross-Sectional Area

Download PDF 194 KB 

Kousik Krishnan, MD, FACC1, Akshay Gupta MD1, Sean M. Halleran, MD1, Dave Chawla MD1, Elizabeth F. Avery, MS2, Julia L. Bienias, ScD2, Richard G. Trohman MD, FACC, FHRS, FAHA1.

1Department of Internal Medicine, Section of Cardiology (Cardiac Electrophysiology Service)

2Department of Preventive Medicine, Section of Biostatistics and Epidemiology, Rush University Medical Center, Chicago, IL

Address for correspondence: Kousik Krishnan, MD, FACC, Section of Cardiology, Cardiac Electrophysiology Service, 1750 W. Harrison, Suite 983 Jelke, Chicago, Illinois 60612. E-mail: kousik_krishnan/at/rush.edu

Disclosures

Kousik Krishnan, M.D.- Investigator (Boston Scientific/Guidant, Medtronic, St. Jude Medical), and Speakers Bureau (Boston Scientific/Guidant)
Akshay Gupta, MD, - None
Sean M. Halleran, MD, - None
Dave Chawla, MD, - None
Elizabeth Avery, MS. – None
Julia L. Bienias, ScD. - None
Richard G. Trohman, M.D. - Investigator (Boston Scientific/Guidant, Medtronic, St. Jude Medical, Vitatron, Wyeth-Ayerst/Wyeth Pharmaceuticals), Advisory Board (Boston Scientific/Guidant), Consultant (Biosense-Webster) and Speakers Bureau (Boston Scientific/Guidant, Medtronic, St. Jude Medical))

Abstract

Background: Right atrial flutter cycle length can prolong in the presence of antiarrhythmic drug therapy. We hypothesized that the cycle length  of right atrial isthmus dependent flutter would correlate with right atrial cross-sectional area measurements.

Methods: 60 patients who underwent ablation for electrophysiologically proven isthmus dependent right atrial flutter, who were not on Class I or Class III antiarrhythmic drugs and had recent 2-dimensional echocardiographic data comprised the study group. Right atrial length and width were measured in the apical four chamber view. Cross-sectional area was estimated by multiplying the length and width. 35 patients had an atrial flutter rate ≥250 bpm (Normal Flutter Group) and 25 patients had an atrial flutter rate < 250 bpm (Slow Flutter Group).

Results: Mean atrial flutter rate was 283 bpm in the normal flutter group and 227 bpm in the slow flutter group. Mean atrial flutter cycle length was 213 ms  in the Normal Flutter Group and 265 ms in the Slow Flutter Group (p<0.0001). Mean right atrial cross sectional area was 1845 mm2 in the Normal Flutter group and 2378 mm2 in the Slow Flutter Group, (p< 0.0001). Using linear regression, CSA was a significant predictor of cycle length (β =0.014 p = 0.0045). For every 1 mm2 increase in cross-sectional area, cycle length is 0.014 ms longer.

Conclusion: In the absence of antiarrhythmic medications, right atrial cross sectional area enlargement correlates with atrial flutter cycle length. These findings provide further evidence that historical rate-related definitions of typical isthmus dependent right atrial are not mechanistically valid.


 Key Words: Atrial Flutter; Reentrant arrhythmias; Catheter Ablation; Electrophysiology Study; Echocardiography; Right Atrium

Abbreviations

Avg: Average
bpm: beats per minute
CSA: Cross-sectional area
CT: Computerized tomography
mm: millimeters
ms: milliseconds
MRI: Magnetic Resonance Imaging
RA: Right Atrium
 
Introduction

The classic definition of atrial flutter includes an atrial rate of 250-350 beats per minute (bpm) without an isoelectric baseline between atrial deflections.[1] It is well known that right atrial flutter cycle length can prolong in the presence of antiarrhythmic medication. Strong sodium channel blockers (flecainide, propafenone) and potassium channel blockers (e.g. ibutilide) decrease trans-isthmus conduction velocity or significantly increase the atrial refractory period. Ibutilide has a strong effect on the atrial mean action potential duration. Amiodarone has both sodium and potassium channel inhibitory effects, however, its impact on both conduction velocity and action potential duration is relatively weaker. [2-5] Little data exists correlating right atrial size with atrial flutter cycle length. One small study correlated acute volume expansion of the right atrium (by negative tilt and inspiration) with atrial flutter cycle length prolongation. [6] We hypothesized that right atrial isthmus dependent flutter cycle length would correlate with right atrial cross-sectional area (CSA) measurements.

Methods

114 consecutive patients who underwent ablation of a right atrial isthmus dependent tachycardia and were not on Class I or Class III antiarrhythmic drugs were screened. All 114 patients had an electrophysiologically proven reentrant arrhythmia with the cavotricuspid isthmus (CTI) as part of the circuit. Of these patients, 60 who had recent 2D echocardiograms were included. The echocardiograms were performed when the patients were in atrial flutter. Right atrial flutter cycle lengths were measured and atrial rates were dichotomized to greater than or equal to 250 bpm or less than 250 bpm. Right atrial length and width dimensions were measured in the apical four chamber view at end diastole and a CSA calculation was made by multiplying the length and width.

Statistical analysis

All data are expressed as mean ± SD unless otherwise noted. The unpaired 2-tailed t test was used to compare continuous variables between the two flutter groups. Linear regression was used to investigate the association between cycle length and CSA. A p-value of <0.05 was considered significant.  

Results

In the group as a whole, mean tachycardia cycle length was 234.9 ± 31.5 ms.  The overall mean atrial flutter rate was 260 ± 35.2 bpm. The overall mean cross sectional area was 2066.9 ± 815.4  mm2.The flutter cycle length was 213 ms  in the Normal Flutter Group and 265 ms in the Slow Flutter Group (p<0.0001). As seen in Table 1, there was a significant difference between slow and normal atrial flutters in both cycle length and cross sectional area.

Table 1


Avg –average, bpm-beats per minute, mm-millimeters, ms-milliseconds, RA-right atrium
std - standard deviation


We modeled cycle length as a function of CSA using linear regression.  The parameter estimate,  β for CSA was 0.014 (s.e. = 0.005, p  = 0.0045, R2 = .131),  such that one additional mm2 of cross sectional area was associated with a 0.014 ms longer cycle length ( a 500 mm2  increase in  right atrial area  would be associated with a 7  ms increase cycle length, see Figure 1). There was one patient with a very high CSA of 4234 mm2. As a sensitivity analysis, we re-fit the model without this person's data; the effect was still significant and β was slightly reduced, to 0.013 (R2 =.100), thus demonstrating that CSA had a 13% influence on the overall flutter cycle length.



Figure 1: Cycle length vs cross sectional area

The scatter that occurs reflects the fact that CSA accounts for 13% of  atrial flutter cycle length and provides indirect proof that other influences such as scarring and anisotrpy are not linear correlates of CSA
Discussion

For many years, definitions of atrial tachyarrhythmias were based solely on rate, with little mention of electrophysiological mechanisms. Atrial rates over 250 bpm were defined as flutter and rates less than 250 bpm were classified as atrial tachycardia, implying a link between rate and arrhythmia mechanism. This definition was revised in 2001, by the Joint Expert Group of the European Society of Cardiology and the Heart Rhythm Society, to eliminate the connection between the atrial rate and the arrhythmia mechanism. Their proposal was to term any regular atrial rhythm ≥100 bpm originating outside the sinus node region as an atrial tachycardia, whether the mechanism is focal or macroreentrant. [7]

Isthmus-dependant atrial flutter is more easily cured with less recurrence than atrial tachycardias. [8-13] If decisions to offer catheter ablation are based strictly on rate criteria (rather than mechanism), our data suggests that a significant number of patients (25/60, 42%) might be excluded. These findings also emphasize the importance of careful diagnostic electrophysiological testing, mapping of activation sequences and pacing to identify concealed entrainment prior to delivery of ablative lesions. Our data corroborates recommendations of The Joint Expert Group of the European Society of Cardiology and the Heart Rhythm Society that atrial arrhythmia definitions should be mechanistic and demonstrates that an enlarged right atrial CSA correlates strongly with atrial flutter cycle length in the absence of antiarrhythmic drug therapy.

Although there is a correlation between atrial flutter cycle length and right atrial size, this relationship is not always linear and does not fully explain cycle length variation in typical atrial flutter. Cycle length is calculated by dividing the distance a wavefront of activation travels, D, by the wavefront's conduction velocity, V (Cycle length = D/V). It is well known that atrial tissue, via the distribution of connexins, prefers longitudinal anisotropic conduction compared to lateral conduction. This preference is even more pronounced than in ventricular tissue. [14] Conduction velocity is affected by cell size, excitability, as well as gap junction (connexin) location and density. [15-17] When the atria dilate due to volume overload, Connexin 43 redistributes within atrial cells to a lateral location, decreasing the normal longitudinal conduction.[18] In addition, fibrosis of the atrial myocardium plays an important role in gap junction disorganization Uncoupling of cellular gap junctions (by atrial fibrosis and dilatation) plays a much larger role in conduction velocity than excitability or cell size.[17,19,20] Therefore, an enlarged atrium would lead to a larger distance traveled (D), and changes in connexin distribution and longitudinal conduction velocity, resulting in a longer flutter cycle length.  The degree that fibrosis uncouples gap junctions will vary between patients.  In patients with dilated atria and mild fibrosis atrial size is likely to be a very important determinant of flutter cycle length. When atrial fibrosis is severe, the effect of scarring on gap junctions (decreasing conduction velocity) may outweigh the impact of atrial dilatation (D increases < V decreases). Such differences account for the absence of linear correlation between right atrial size and flutter cycle length.

Rate-related historical definitions of typical isthmus dependent right atrial flutter have obvious limitations and indications for catheter ablation of the cavotricuspid isthmus should be expanded accordingly. Careful evaluation of the 12-lead electrocardiogram combined with the right atrial CSA will help identify patients likely to benefit from isthmus ablation, despite atrial rates below 250 bpm.[21]

Study Limitations

We excluded patients on antiarrhythmic medications known to affect conduction velocity and the atrial refractory period. In addition, all patients were supine, sedated and in the post-absorptive state, thus the interplay of volume loading and autonomic tone should be uniformly distributed in both groups under analysis. However, since echocardiography and electrophysiologic data collection were performed at different times, autonomic tone and/or volume loading could have been different at these two time points, accounting for some variability in individual patients' atrial rate data. Given the limitations of obtaining a true cross sectional area, our estimates may underestimate the true right atrial size. A better measure of the distance the wavefront of activation travels may require calculating an atrial perimeter. Finally, while the importance of conduction velocity in determining cycle length is well known, this measurement is difficult to obtain in vivo.

Conclusions

The cycle length of typical atrial flutter is the result of a complex interaction between autonomic tone, atrial volume loading, effects of drugs on the excitable gap and intraatrial conduction time. [2-5,22] A well described correlation exists between slower right atrial flutter rates and Class I and III antiarrhythmic medication use. We have demonstrated a correlation between flutter cycle length and right atrial CSA. It is, therefore, likely that right atrial size has a significant impact on atrial flutter circuit wavelength. The non-linearity of the correlation between right atrial CSA and cycle length suggest that the multitude of structural and cellular factors that impact atrial impulse conduction velocity may have potential to overshadow the effect of right atrial CSA on flutter cycle length.

A well validated measurement of right atrial volume does not currently exist without expensive imaging (CT, MRI). Right atrial length and width measurements are readily available in most cardiology offices and hospitals. CSA calculation is simple, inexpensive and may be a useful tool in clinical arrhythmic evaluation.

References

1. Waldo AL: Atrial Flutter: From mechanism to treatment. In Camm AJ, ed: Clinical Approaches to Tachyarrhythmias. Armonk, NY, Futura Publishing, 2001, pp1-56.

2. Stambler BS, Wood MA, Ellenbogen KA: Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.  J Am Coll Cardiol. 1996;27:453-61.

3. Inoue H, Yamashita T, Nozaki A, Sugimoto T: Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol. 1991;18:1098-104.

4. Tai CT, Chen SA, Feng AN, Yu WC, Chen YJ, Chang MS: Electropharmacologic effects of Class I and Class III antiarrhythmic drugs on typical atrial flutter: insights into the mechanism of termination. Circulation 1998;97:1935-45.

5. Stambler BS, Wood MA, Ellenbogen KA: Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation. 1997;96:4298-306.

6. Wulliemin P, Del Bufalo A, Schlaepfer J, Fromer M, Kappenberger L: Relation between cycle length, volume, and pressure in type I atrial flutter. Pacing Clin Electrophysiol. 1994;17:1391-8.

7. Saoudi N, Cosio F, Waldo A, Chen S, Iesaka Y, Lesh M, Saksena S, Salerno J, Schoels W: Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol. 2001;12:852-66.

8. Lesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ, Kwasman MA, Grogin HR, Griffin JC: Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994;89:1074-89.

9. Kay GN, Chong F, Epstein AE, Dailey SM, Plumb. VJ: Radiofrequency ablation for treatment of primary atrial tachycardias. J Am Coll Cardiol. 1993;21:901-9

10. Tracy CM, Swartz JF, Fletcher RD, Hoops HG, Solomon AJ, Karasik PE, Mukherjee D: Radiofrequency catheter ablation of ectopic atrial tachycardia using paced activation sequence mapping. J Am Coll Cardiol.1993;21:910-7.

11. Tai CT, Chen SA, Chiang CE, Lee SH, Wen ZC, Huang JL, Chen YJ, Yu WC, Feng AN, Lin YJ, Ding YA, Chang MS: Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 1998; 9:115-21.

12. Hsieh MH, Tai CT, Chiang CE, Tsai CF, Yu WC, Chen YJ, Ding YA, Chen SA. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J Interv Card Electrophysiol. 2002;7:225-31.

13. Gilligan DM, Zakaib JS, Fuller I, Shepard RK, Dan D, Wood MA, Clemo HF, Stambler BS, Ellenbogen KA. Long-term outcome of patients after successful radiofrequency ablation for typical atrial flutter. Pacing Clin Electrophysiol. 2003;26:53-8.

14. Saffitz JE, Kanter HL, Green KG, Tolley TK, Beyer EC. Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res. 1994;74:1065-70.

15. Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol. 1994;24:1124-32.

16. Spach MS, Heidlage JF, Barr RC, Dolber PC. Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm. 2004;1:500-15.

17. Jongsma HJ, Wilders R. Gap junctions in cardiovascular disease. Circ Res. 2000;86:1193-7.

18. Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud JF, Dunia I, Segretain D, Hatem SN. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res. 2006;72:69-79.

19. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84:431-88.

20. Koura T, Hara M, Takeuchi S, Ota K, Okada Y, Miyoshi S, Watanabe A, Shiraiwa K, Mitamura H, Kodama I, Ogawa S. Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping: preferential direction of conduction block changes from longitudinal to transverse with increasing age. Circulation. 2002;105:2092-8.

21. Wood, KA , Eisenberg, SJ , Kalman, JM , Drew, BJ , Saxon, LA , Lee, RJ , Lesh, MD , Scheinman, MM: Risk of thromboembolism in chronic atrial flutter. American Journal of Cardiology 1997;79,1043-1047

22. Stambler BS, Ellenbogen KA: Elucidating the mechanisms of atrial flutter cycle length variability using power spectral analysis techniques. Circulation.1996;94:2515-25.

Home Page Current Issue List of Editors